1280399

CorePharma, LLC — FEI 3002535019

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Middlesex, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)